2025-09-27 (六) 14:10 ~ 18:00

The two-day symposium “Keep Going Toward Victory in Fighting Lung Cancer” will be held on September 27–28 in Chiayi. Day 1 highlights advances in NSCLC, including PD-L1 plus anti-angiogenic therapy, precision oncology with re-biopsy and NGS, and updates from WCLC 2025. ALK+ lung cancer management with ALK inhibitors will also be discussed. Day 2 focuses on post-surgical ALK+ NSCLC care from the ALINA study, precision strategies for EGFRm+ NSCLC, and evolving approaches in SCLC, such as IO-based combinations and molecular subtyping. The meeting gathers leading experts to share clinical insights and future perspectives.